T1	Intervention 557 627	oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13)
T2	Intervention 688 882	Subjects underwent pre- and post-treatment lab testing to evaluate plasma reduced glutathione, oxidized glutathione, cysteine, taurine, free and total sulfate, and whole-blood glutathione levels
